| NOBEL Pharma Schweiz AG - Duloxetin NOBEL uro 20 mg, Magensaftresistente Hartkapseln | | 68564 | | 01 | | Duloxetin NOBEL uro 20 mg | | Magensaftresistente Hartkapseln | | N06AX21 | | Duloxetin | | 10.03.2023 | | |
| | Composition | | duloxetinum 20 mg ut duloxetini hydrochloridum, sacchari sphaerae corresp. saccharum 37.97 mg et maydis amylum, hypromellosum, saccharum 5.74 mg, talcum, triethylis citras, hypromellosi acetas succinas, E 171, Kapselhülle: gelatina, E 171, E 132, pro capsula. | | Packungsbestandteile | | Magensaftresistente Hartkapseln | | | | Principe actif | Concentr. |
|---|
| Duloxetinum | 20 mg |
| | | | Agents auxilliaires | Concentr. | informations additionels |
|---|
| E 132 | | color. | | E 171 | | color. | | Gelatina | | Kapselhülle | | Hypromellosi Acetas Succinas | | | | Hypromellosum | | | | Maydis Amylum | | | | Pro Capsula | | | | Sacchari Sphaerae | | | | Saccharum | 5.74 mg | | | Talcum | | | | Triethylis Citras | | |
|
| | numéro d'emballage | Taille des présentations | PEF | PP | Cat. | LS | Hors commerce (MedRef) |
|---|
| 001 | 28 | DDP | DDP | B | | Non | | 002 | 98 | DDP | DDP | B | | Non |
|
|
